Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

is an underdiagnosed and underreported etiology of pneumonia. serogroup 1 (LpSG1) is thought to be the most common pathogenic subgroup. This assumption is based on the frequent use of a urinary antigen test (UAT), only capable of diagnosing LpSG1. We aimed to explore the frequency of infections in individuals diagnosed with pneumonia and the performance of diagnostic methods for detecting infections. We conducted a scoping review to answer the following questions: (1) "Does nucleic acid testing (NAT) increase the detection of non- serogroup 1 compared to non-NAT?"; and (2) "Does being immunocompromised increase the frequency of pneumonia caused by non- serogroup 1 compared to non-immunocompromised individuals with Legionnaires' disease (LD)?". Articles reporting various diagnostic methods (both NAT and non-NAT) for pneumonia were extracted from several databases. Of the 3449 articles obtained, 31 were included in our review. The most common species were found to be , , and unidentified species appearing in 1.4%, 0.9%, and 0.6% of pneumonia cases. Nearly 50% of cases were caused by unspecified species or serogroups not detected by the standard UAT. NAT-based techniques were more likely to detect than non-NAT-based techniques. The identification and detection of and serogroups other than serogroup 1 is hampered by a lack of application of broader pan- or pan-serogroup diagnostics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11510479PMC
http://dx.doi.org/10.3390/pathogens13100857DOI Listing

Publication Analysis

Top Keywords

legionnaires' disease
8
scoping review
8
diagnostic methods
8
non- serogroup
8
serogroup compared
8
pneumonia
5
adequacy current
4
current legionnaires'
4
disease diagnostic
4
diagnostic practices
4

Similar Publications

Memory T cells, a sizable compartment of the mature immune system, enable enhanced responses upon re-infection with the same pathogen. We have recently shown that virus-experienced innate acting T (T) cells can modulate infectious or autoimmune diseases through TCR-independent IFN-γ production. However, how these cells arise remains unclear.

View Article and Find Full Text PDF

is a pathogen of global health importance due to its role in causing Legionnaires' disease (LD), a severe form of community-acquired pneumonia. Throughout the USA and Europe, is often identified as the primary cause of LD, but in countries such as New Zealand and Australia, where testing for non- species is employed systematically, high rates of are reported. Development of genomic tools to track outbreaks and identify infection sources for has lagged behind that of .

View Article and Find Full Text PDF

Background: In 2021-2022, Queensland, Australia observed an increase in Legionnaire's disease cases, predominantly due to Legionella longbeachae. This study assessed seroprevalence at time points 2016 and 2023, representing before and after the higher incidence and explored if demographic, environmental and geographical factors associated with legionellosis seroprevalence.

Methods: A total of 1001 human plasma samples (496 from 2016/505 from 2023) were analysed for the presence of Legionella antibodies (IgG) using indirect immunofluorescence assays.

View Article and Find Full Text PDF

Host cells provide intracellular bacteria with protection from harsh environmental conditions and immune responses, but for many intracellular pathogens, this protection does not appear to be absolute as once thought. Bacteriophages that can kill bacteria inside host cells have been identified for pathogens including , , and species. Even in pathogens for which no stable phages have been isolated, such as , the presence of phage defense systems suggests phage susceptibility.

View Article and Find Full Text PDF

pneumonia is a significant cause of community-acquired pneumonia that often requires timely and effective treatment. While fluoroquinolones and macrolides are the recommended first-line therapies, doxycycline offers an alternative with favorable pharmacokinetics, safety, and minimal drug-drug interactions. We describe three hospitalized patients with pneumonia who received doxycycline monotherapy.

View Article and Find Full Text PDF